Literature DB >> 20087078

A case of rhabdomiolysis associated with raltegravir use.

Luca Dori, Anna R Buonomini, Magda Viscione, Loredana Sarmati, Massimo Andreoni.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20087078     DOI: 10.1097/QAD.0b013e328334cc4a

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  7 in total

1.  Nephrotoxicity of HAART.

Authors:  Robert Kalyesubula; Mark A Perazella
Journal:  AIDS Res Treat       Date:  2011-08-15

2.  Role of raltegravir in the management of HIV-1 infection.

Authors:  N Lance Okeke; Charles Hicks
Journal:  HIV AIDS (Auckl)       Date:  2011-07-15

3.  Severe rhabdomyolysis and acute asymptomatic pancreatitis following the concomitant use of Biktarvy in the setting of hyperosmolar diabetic crisis.

Authors:  Sylvain Raoul Simeni Njonnou; Sophie Henrard; Lamya Noure; Jean-Christophe Goffard
Journal:  BMJ Case Rep       Date:  2020-07-01

4.  Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy.

Authors:  Guan-Jhou Chen; Hsin-Yun Sun; Aristine Cheng; Yu-Chung Chuang; Yu-Shan Huang; Kuan-Yin Lin; Yi-Chia Huang; Wen-Chun Liu; Pei-Ying Wu; Chien-Ching Hung; Shan-Chwen Chang
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

5.  A suspected case of hyponatraemia induced rhabdomyolysis: a case report.

Authors:  Edward Reakes; Douglas Drak; David Gracey
Journal:  BMC Nephrol       Date:  2022-05-11       Impact factor: 2.585

Review 6.  HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety.

Authors:  Kimberly K Scarsi; Joshua P Havens; Anthony T Podany; Sean N Avedissian; Courtney V Fletcher
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546

7.  Severe Rhabdomyolysis as an Unusual Presentation of Primary Human Immunodeficiency Virus Infection.

Authors:  Myint M Noe; Akriti G Jain; Sonia Shahid; Umair Majeed
Journal:  Cureus       Date:  2018-07-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.